World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
81
Citations
22409
World Ranking
16722
National Ranking
670

Overview

Anna Sapino is affiliated with the University of Turin in Italy and has contributed extensively to research primarily in medicine, with significant work spanning biochemistry, genetics, and molecular biology. Their research largely focuses on oncology, cancer research, molecular biology, pathology and forensic medicine, and radiology.

The scientist's research topics include cancer genomics and diagnostics, breast cancer treatment studies, HER2/EGFR in cancer research, genetic factors in colorectal cancer, breast lesions and carcinomas, cancer cells and metastasis, and molecular biology techniques and applications.

Anna Sapino has published papers in several journals, with some of the recent works including:

  • The 2019 World Health Organization classification of tumours of the breast (2020, Histopathology)
  • Evolving concepts in HER2 evaluation in breast cancer: Heterogeneity, HER2-low carcinomas and beyond (2020, Seminars in Cancer Biology)
  • Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial (2022, Nature Medicine)
  • Basic principles of biobanking: from biological samples to precision medicine for patients (2021, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin)
  • Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer (2020, npj Breast Cancer)

Frequent co-authors collaborating with Anna Sapino include:

  • Caterina Marchiò
  • Enrico Berrino
  • Sara E. Bellomo
  • Filippo Montemurro
  • Isabella Castellano

The most common publication venues for their research output are:

  • Pathologica
  • ESMO Open
  • Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  • Cancers
  • Research Square (Research Square)

Best Publications

  • A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer.

    Andrea Bertotti;Giorgia Migliardi;Francesco Galimi;Francesco Sassi

  • The 2019 World Health Organization classification of tumours of the breast.

    Puay Hoon Tan;Ian Ellis;Kimberly Allison;Edi Brogi

  • Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance

    Eswaran Devarajan;Aysegul A. Sahin;Jack S. Chen;Raghu R. Krishnamurthy

  • Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines.

    Paola Cassoni;Mauro Papotti;Corrado Ghè;Filomena Catapano

  • Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer

    G. Cserni;D. Gregori;F. Merletti;A. Sapino

  • Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines

    G. Cserni;I. Amendoeira;N. Apostolikas;J.P. Bellocq

  • The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group.

    Khalid El Bairi;Harry R Haynes;Harry R Haynes;Elizabeth Blackley;Susan Fineberg

  • Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers

    Isabella Castellano;Elena Allia;Valeria Accortanzo;Anna Maria Vandone

  • Evolving concepts in HER2 evaluation in breast cancer: Heterogeneity, HER2-low carcinomas and beyond

    Caterina Marchiò;Laura Annaratone;Ana Marques;Laura Casorzo

  • Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up

    Sara Bustreo;Simona Osella-Abate;Paola Cassoni;Michela Donadio

  • Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology.

    G Cserni;I Amendoeira;N Apostolikas;J P Bellocq

  • Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray-based CGH analysis†

    Caterina Marchiò;Maryou B Lambros;Patrizia Gugliotta;Ludovica Verdun Di Cantogno

  • SF3B1 mutations constitute a novel therapeutic target in breast cancer

    Sarah L. Maguire;Andri Leonidou;Patty Wai;Caterina Marchiò;Caterina Marchiò

  • The requirements of a specialist Breast Centre

    A. R. M. Wilson;L. Marotti;S. Bianchi;L. Biganzoli

  • HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breast

    Sophie Michelle Doublier;Dimas Carolina Belisario;Manuela Polimeni;Laura Annaratone

  • Expression of the neuroendocrine phenotype in carcinomas of the breast.

    A Sapino;L Righi;P Cassoni;M Papotti

  • Ultrasonographically-guided fine-needle aspiration of axillary lymph nodes: role in breast cancer management

    A Sapino;P Cassoni;E Zanon;F Fraire

  • Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast

    C Marchiò;C Marchiò;M Iravani;R Natrajan;MB Lambros

  • Specific demonstration of myoepithelial cells by anti-alpha smooth muscle actin antibody.

    Patrizia Gugliotta;Anna Sapino;Luigia Macri;Omar Skalli

  • PARP Inhibitors in Ovarian Cancer

    Gloria Mittica;Eleonora Ghisoni;Gaia Giannone;Sofia Genta

Frequent Co-Authors

Mauro Papotti
Mauro Papotti University of Turin
Giuseppe Viale
Giuseppe Viale University of Milan
Massimo Aglietta
Massimo Aglietta University of Turin
Enzo Medico
Enzo Medico University of Turin
Giorgio Inghirami
Giorgio Inghirami Cornell University
Jelle Wesseling
Jelle Wesseling Leiden University Medical Center
Silvia Giordano
Silvia Giordano University of Turin
Jorge S. Reis-Filho
Jorge S. Reis-Filho Memorial Sloan Kettering Cancer Center
Paolo M. Comoglio
Paolo M. Comoglio FIRC Institute of Molecular Oncology
Salvatore Siena
Salvatore Siena University of Milan

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine does not always mean attending medical school. Many students opt for flexible, affordable alternatives in related healthcare fields through online programs. One popular choice is pursuing an online nursing doctorate, which allows experienced nurses to advance into research or leadership roles without leaving their jobs.

For those starting as registered nurses, understanding the average cost of rn to bsn programs is key when weighing education options. Online RN to BSN programs are designed for working professionals seeking career advancement with greater schedule flexibility and potentially lower costs.

If you hold a non-nursing bachelor’s degree but want to transition into nursing, online direct entry msn programs for non-nursing majors offer an efficient path to becoming a nurse, often in just a few years.

For those concerned about admission barriers, some schools are known for being accessible. Review the easiest rn program options to help you get started on a healthcare career pathway that fits your goals and background.

Best Scientists Citing Anna Sapino

Trending Scientists

Recently Published Articles